It's all over the internet: a new non-stimulant medication approved by the FDA for treatment of ADHD. but is Viloxazine (Qelbree) going to be a game changer? Find out!
We hope this trio of 60-second psych podcasts is a start at addressing the impact of systemic inequity:
Promoting Assertiveness in Adolescents
Preventing Trauma With Racial Socialization
You Might Also Enjoy...
It's all over the internet: a new non-stimulant medication approved by the FDA for treatment of ADHD. but is Viloxazine (Qelbree) going to be a game changer? Find out!
There's so much marketing for genetic testing, but does it really help clinical care? Listen to our interview with Dr. Aaron Besterman about how genetic tests work, and what can be reliably taken away from them.
For 17 years, since the FDA black box warning about suicidality with antidepressants, our community has quoted data that downplays this concern. We were wrong. We were deceived. Antidepressants can be lifesaving, but there really is a duty to warn.
Returning guest Dr. Joshua Feder and I discuss why it is so important to emphasize that accepting reality is a process that parents need to be supported in, and the ways in which we can do this.
While medication is the mainstay of treating symptoms in ADHD, Edward Hallowell, MD, shares a positive, relationship-based approach to ADHD with practical strategies to help children and adolescents manage ADHD.
Air pollution, including particulate matter from forest fires, is a leading cause of health problems. It is also linked to psychiatric problems in children and adolescents. We take a closer look at the evidence and clinical implications in this episode.